Advanced Solid Tumors Treated with Cediranib: Comparison of Dynamic Contrast-enhanced MR Imaging and CT as Markers of Vascular Activity-Reference-Cited by-同舟云学术

Advanced Solid Tumors Treated with Cediranib: Comparison of Dynamic Contrast-enhanced MR Imaging and CT as Markers of Vascular Activity

Published:2012-11 Issue:2 Volume:265 Page:426-436
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Messiou Christina,Orton Matthew,Ang Joo Ern,Collins David J.,Morgan Veronica A.,Mears Dorothy,Castellano Isabel,Papadatos-Pastos Dionysis,Brunetto Andre,Tunariu Nina,Mann Helen,Tessier Jean,Young Helen,Ghiorghiu Dana,Marley Sarah,Kaye Stan B.,deBono Johann S.,Leach Martin O.,deSouza Nandita M.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.12112565

Reference38 articles.

1. RECIST revisited: A review of validation studies on tumour assessment

2. Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)

3. Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors

4. Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate

5. Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. X-ray, digital tomographic fusion, CT, and MRI in early ischemic necrosis of the femoral head;Medicine;2024-01-12

2. Mapping Spatiotemporal Heterogeneity in Tumor Profiles by Integrating High-Throughput Imaging and Omics Analysis;ACS Omega;2023-02-07

3. The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol;BMC Cancer;2021-11-18

4. Descriptive analysis of MRI functional changes occurring during reduced dose radiotherapy for myxoid liposarcomas;The British Journal of Radiology;2021-10-01

5. Achievement in active agent structures as a power tools in tumor angiogenesis imaging;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08